Skip to main content

Eli Lilly & Co

LLY
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000059478

In the last 90 days, Eli Lilly & Co insiders filed 0 open-market purchases and 3 sales; 4,643 institutions reported holding it in 13F filings for Q2 2026, worth $942.7B in total; 4 superinvestors hold it, including ARK Invest and Soros Fund Management.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Eli Lilly & Co insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
3 filings
3 insiders, $16.0M in total
Insiders trading
3
Net value
−$16.0M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Eli Lilly & Co, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Eli Lilly & Co
NameTitleLast reported holdingLast filingFilings, past year
Sulzberger GabrielleDirector3,012Sep 22, 202612
Luciano Juan RDirector16,957Sep 22, 202612
Fyrwald J ErikDirector75,536Sep 22, 202612
Alvarez RalphDirector55,838Sep 22, 202612
Seymour MelissaEVP, Global Quality1,038Sep 11, 20262
Hernandez EdgardoEVP & Pres., Mfg. Operations46,083Sep 4, 20263
Dozier EricEVP, Chief People Officer14,239Sep 4, 20264
Jonsson PatrikEVP & President, LLY Int'l54,147Aug 18, 20263
Zakrowski Donald ASVP, Finance, & CAO1,526Aug 11, 20264
Hakim AnatEVP, GC & Secretary11,875IndirectAug 10, 20263
Yuffa IlyaEVP&Pres, LLY USA&Global Capab29,804Jun 11, 20263
Lilly Endowment IncOther: Former 10% Shareholder91,881,150May 7, 202634
Montarce LucasEVP & CFO16,258Feb 18, 20262
Custer Kenneth L.EVP & President, Card Met Hlth10,141Feb 18, 20262
Brown Adrienne SEVP, President LLY Imm5,142Feb 18, 20262
Rau DiogoEVP & CIDO26,397Feb 12, 20262
Ricks David APresident, Chair, and CEO571,715Feb 11, 20263
Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBD26,627Feb 11, 20262
Skovronsky DanielEVP, CS&PO & Pres. LRL160,072Feb 11, 20263
Hedley Mary LynneDirector2,253Dec 16, 20253
Moeller Jon RDirector304Nov 18, 20251
Baicker KatherineDirector23,503Nov 18, 20251
Kaelin William G JrDirector21,837Nov 18, 20251
Jackson JamereDirector9,635Nov 18, 20251
Johnson Kimberly HDirector3,265Nov 18, 20251
White Anne E.EVP & Pres, Lilly Neuroscience74,210Feb 12, 20250
Walker KarenDirector6,249Nov 20, 20240
Norton JohnaEVP, Global Quality25,428Jun 3, 20240
Ashkenazi AnatEVP & CFO42,330Feb 14, 20240
Weems AlonzoEVP, ERM & CECO7,951Feb 14, 20240
Runge Marschall SDirector16,593Nov 21, 20230
Tai Jackson PDirector63,524Apr 19, 20230
Pusey Leigh AnnEVP, Corp. Affairs & Comm.31,641Feb 14, 20230
Mason Michael BEVP & Pres., Lilly Diabetes39,284Feb 14, 20230
Fry Stephen FSVP, HR & Diversity152,631Feb 11, 20220
Eskew Michael LDirector45,080Nov 17, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 31, 2024 (view filing)Jan 301 dayLilly Endowment Inc10% OwnerSSale−76.2K$645.21−$49.2M−0.1%99.4M after2 lots
Jan 30, 2024 (view filing)Jan 291 dayLilly Endowment Inc10% OwnerSSale−54.0K$645.07−$34.9M−0.1%99.5M after
Jan 17, 2024 (view filing)Jan 161 dayLilly Endowment Inc10% OwnerSSale−1.18K$645.60−$761.8K0.0%99.5M after2 lots
Jan 12, 2024 (view filing)Jan 111 dayLilly Endowment Inc10% OwnerSSale−12.3K$634.13−$7.83M0.0%99.5M after8 lots
Jan 11, 2024 (view filing)Jan 101 dayLilly Endowment Inc10% OwnerSSale−163.7K$630.59−$103.2M−0.2%99.6M after7 lots
Jan 10, 2024 (view filing)Jan 91 dayLilly Endowment Inc10% OwnerSSale−34.5K$631.81−$21.8M0.0%99.7M after4 lots
Jan 5, 2024 (view filing)Jan 41 dayLilly Endowment Inc10% OwnerSSale−14.4K$630.28−$9.07M0.0%99.8M after2 lots
Nov 6, 2023 (view filing)Nov 6Same dayZakrowski Donald ASVP, Finance, & CAOSSale−670$571.10−$382.6K−12.5%4.71K after10b5-1
Oct 12, 2023 (view filing)Oct 111 dayLilly Endowment Inc10% OwnerSSale−215.0K$605.44−$130.2M−0.2%99.8M after5 lots
Sep 13, 2023 (view filing)Sep 121 dayWeems AlonzoEVP, ERM & CECOSSale−1.15K$590.98−$678.4K−12.9%7.76K after10b5-1
Sep 8, 2023 (view filing)Sep 71 dayLilly Endowment Inc10% OwnerSSale−210.0K$571.41−$120.0M−0.2%100.0M after11 lots
Sep 1, 2023 (view filing)Aug 311 dayLilly Endowment Inc10% OwnerSSale−46.5K$554.82−$25.8M0.0%100.2M after4 lots
Aug 31, 2023 (view filing)Aug 301 dayLilly Endowment Inc10% OwnerSSale−6.18K$555.32−$3.43M0.0%100.2M after4 lots
Aug 30, 2023 (view filing)Aug 291 dayLilly Endowment Inc10% OwnerSSale−28.7K$554.10−$15.9M0.0%100.2M after2 lots
Aug 29, 2023 (view filing)Aug 281 dayLilly Endowment Inc10% OwnerSSale−37.7K$546,751.75−$20.6B0.0%100.3M after2 lotsPrice outlier
Aug 28, 2023 (view filing)Aug 253 daysLilly Endowment Inc10% OwnerSSale−63.6K$554.39−$35.2M−0.1%100.3M after3 lots
Aug 25, 2023 (view filing)Aug 241 dayLilly Endowment Inc10% OwnerSSale−21.0K$554.74−$11.6M0.0%100.4M after3 lots
Aug 24, 2023 (view filing)Aug 231 dayLilly Endowment Inc10% OwnerSSale−1.31K$555.69−$726.3K0.0%100.4M after
Aug 22, 2023 (view filing)Aug 211 dayZakrowski Donald ASVP, Finance, & CAOSSale−600$546.51−$327.9K−10.0%5.38K after10b5-1
Aug 16, 2023 (view filing)Aug 151 dayLilly Endowment Inc10% OwnerSSale−50.2K$543.72−$27.3M0.0%100.4M after9 lots
Aug 15, 2023 (view filing)Aug 141 dayLilly Endowment Inc10% OwnerSSale−164.8K$539.08−$88.8M−0.2%100.4M after5 lots
Aug 14, 2023 (view filing)Aug 113 daysLilly Endowment Inc10% OwnerSSale−83.0K$528.50−$43.9M−0.1%100.6M after4 lots
Aug 11, 2023 (view filing)Aug 101 dayLilly Endowment Inc10% OwnerSSale−3.00K$528.14−$1.58M0.0%100.7M after
Aug 10, 2023 (view filing)Aug 91 dayLilly Endowment Inc10% OwnerSSale−124.0K$528.83−$65.6M−0.1%100.7M after5 lots
Aug 9, 2023 (view filing)Aug 81 dayLilly Endowment Inc10% OwnerSSale−204.4K$523.74−$107.1M−0.2%100.8M after29 lots
Jul 24, 2023 (view filing)Jul 213 daysLilly Endowment Inc10% OwnerSSale−591$466.62−$275.8K0.0%101.0M after
Jul 3, 2023 (view filing)Jun 303 daysLilly Endowment Inc10% OwnerSSale−164.1K$467.60−$76.7M−0.2%101.0M after5 lots
Jun 30, 2023 (view filing)Jun 291 dayLilly Endowment Inc10% OwnerSSale−44.1K$465.08−$20.5M0.0%101.2M after
Jun 30, 2023 (view filing)Jun 282 daysLilly Endowment Inc10% OwnerSSale−11.8K$465.40−$5.47M0.0%101.2M after2 lots
Jun 23, 2023 (view filing)Jun 221 dayLilly Endowment Inc10% OwnerSSale−107.0K$459.29−$49.2M−0.1%101.2M after8 lots
Jun 22, 2023 (view filing)Jun 211 dayLilly Endowment Inc10% OwnerSSale−31.5K$454.13−$14.3M0.0%101.4M after2 lots
Jun 21, 2023 (view filing)Jun 201 dayLilly Endowment Inc10% OwnerSSale−34.2K$454.08−$15.5M0.0%101.4M after
Jun 20, 2023 (view filing)Jun 164 daysLilly Endowment Inc10% OwnerSSale−25.0K$455.50−$11.4M0.0%101.4M after3 lots
Jun 16, 2023 (view filing)Jun 151 dayLilly Endowment Inc10% OwnerSSale−27.4K$454.14−$12.4M0.0%101.4M after2 lots
Jun 15, 2023 (view filing)Jun 14-151 dayNorton JohnaEVP, Global QualitySSale−3.29K$446.15−$1.47M−9.9%30.1K after2 lots10b5-1
Jun 2, 2023 (view filing)Jun 11 dayJonsson PatrikEVP&Pres, LLY Imm, LLY USA&CCOSSale−6.00K$429.46−$2.58M−14.0%36.9K after10b5-1
May 22, 2023 (view filing)May 193 daysLilly Endowment Inc10% OwnerSSale−194.4K$442.61−$86.0M−0.2%101.5M after6 lots
May 16, 2023 (view filing)May 151 dayZakrowski Donald ASVP, Finance, & CAOSSale−600$435.29−$261.2K−9.1%5.98K after10b5-1
May 15, 2023 (view filing)May 123 daysLilly Endowment Inc10% OwnerSSale−20.6K$442.77−$9.14M0.0%101.7M after3 lots
May 4, 2023 (view filing)May 31 dayLilly Endowment Inc10% OwnerSSale−178.3K$426.41−$76.0M−0.2%101.7M after18 lots
May 3, 2023 (view filing)May 21 dayLilly Endowment Inc10% OwnerSSale−41.7K$409.75−$17.1M0.0%101.9M after3 lots
May 1, 2023 (view filing)Apr 283 daysLilly Endowment Inc10% OwnerSSale−225.0K$398.48−$89.7M−0.2%101.9M after9 lots
Apr 7, 2023 (view filing)Apr 61 dayLilly Endowment Inc10% OwnerSSale−130.3K$367.27−$47.9M−0.1%102.1M after6 lots
Apr 6, 2023 (view filing)Apr 51 dayLilly Endowment Inc10% OwnerSSale−69.7K$363.37−$25.3M−0.1%102.3M after2 lots
Apr 4, 2023 (view filing)Apr 31 dayLilly Endowment Inc10% OwnerSSale−210.0K$350.49−$73.6M−0.2%102.3M after3 lots
Apr 3, 2023 (view filing)Mar 313 daysLilly Endowment Inc10% OwnerSSale−205.0K$342.01−$70.1M−0.2%102.5M after3 lots
Mar 27, 2023 (view filing)Mar 243 daysLilly Endowment Inc10% OwnerSSale−200.0K$335.83−$67.2M−0.2%102.7M after2 lots
Mar 13, 2023 (view filing)Mar 103 daysWeems AlonzoEVP, ERM & CECOSSale−1.00K$318.85−$318.9K−10.1%8.91K after
Mar 1, 2023 (view filing)Feb 272 daysZakrowski Donald ASVP, Finance, & CAOSSale−600$322.47−$193.5K−8.4%6.58K after
Feb 14, 2023 (view filing)Feb 10-134 daysWhite Anne E.EVP & Pres, Lilly NeuroscienceSSale−5.00K$344.62−$1.72M−7.9%57.9K after2 lots